PHR
Phreesia, Inc.
NYSE · Healthcare · Medical - Healthcare Information Services · US
$11.28
+3.11%Year over year
Reported trailing growth
- Revenue
- +12.9%
- EBITDA
- +675.2%
- EBIT
- +161.7%
- EPS
- -64.5%
- Free cash flow
- +122.1%
- Operating cash flow
- +76.7%
Forward estimates
Based on analyst estimates
- Revenue
- +3.0%
- EBITDA
- +74.7%
- EPS
- +233.9%
Three-year CAGR
- Revenue
- +19.6%
- EBITDA
- +215.2%
- EBIT
- +88.6%
- Net income
- +103.9%
- EPS
- +103.8%
- Free cash flow
- +716.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jul 1, 2026